MariMed Inc. (MRMD) CEO settles RSUs, 10,612 shares withheld for taxes
Rhea-AI Filing Summary
MARIMED INC. President and CEO Jon R. Levine reported on July 15, 2026 the vesting and settlement of 30,625 restricted stock units into common stock and a related 10,612-share tax-withholding disposition. Following these transactions, he directly holds 21,358,631 common shares, with 91,875 RSUs remaining under the grant that will vest in three equal installments on October 15, 2026, January 15, 2027 and April 15, 2027. An additional 6,684,640 shares are held in a family trust for his spouse and children, for which he disclaims beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,013 shares
Net Buy
4 txns
Insider
Levine Jon R
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) F1, F4 | 30,625 | $0.00 | $0.00 |
| Exercise | Common stock F1 | 30,625 | $0.00 | $0.00 |
| Tax Withholding | Common stock F2 | 10,612 | $0.0662 | $702.51 |
| holding | Common stock F3 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units (RSU) — 91,875 shares (Direct);
Common stock — 21,358,631 shares (Direct);
Common stock — 6,684,640 shares (Indirect, By the Jon Levine Family Trust)
Footnotes (4)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Key Figures
RSUs converted to common shares: 30,625 shares
Shares withheld for taxes: 10,612 shares
Direct common shares held: 21,358,631 shares
+3 more
6 metrics
RSUs converted to common shares
30,625 shares
Restricted stock units converted to common stock on July 15, 2026
Shares withheld for taxes
10,612 shares
Common shares withheld to satisfy tax obligations on July 15, 2026
Direct common shares held
21,358,631 shares
Direct holdings of Jon R. Levine after reported transactions
Unvested RSUs remaining
91,875 RSUs
RSU balance from April 15, 2026 grant after July 15, 2026 vesting
Family trust shares
6,684,640 shares
Shares held by the Jon Levine Family Trust; beneficial ownership disclaimed
Tax withholding price
$0.0662 per share
Per-share value used for the 10,612-share tax-withholding disposition
Key Terms
Restricted Stock Units (RSU), tax withholding obligations, beneficial ownership, Section 16
4 terms
Restricted Stock Units (RSU) financial
"The RSUs were granted on April 15, 2026; the remaining RSUs..."
tax withholding obligations financial
"withheld by the Issuer to satisfy tax withholding obligations in connection..."
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16..."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity transactions did MariMed (MRMD) report for Jon R. Levine on July 15, 2026?
MariMed President and CEO Jon R. Levine reported the conversion of 30,625 RSUs into common stock and a related 10,612-share disposition to cover tax withholding obligations, all dated July 15, 2026, as part of his equity compensation activity.
What RSU balance and vesting schedule does Jon R. Levine have at MariMed (MRMD)?
Following the July 15, 2026 vesting, Jon R. Levine has 91,875 RSUs remaining from an April 15, 2026 grant. These RSUs will vest in three equal installments on October 15, 2026, January 15, 2027 and April 15, 2027, subject to the award agreement.
How are family-trust holdings treated in Jon R. Levine’s MariMed (MRMD) ownership disclosures?
An indirect holding of 6,684,640 common shares is reported as held by the Jon Levine Family Trust for his spouse and children. Levine disclaims beneficial ownership of these securities, meaning he does not concede economic or voting control for Section 16 purposes.
Were Jon R. Levine’s MariMed (MRMD) equity transactions made under a Rule 10b5-1 trading plan?
These transactions were not indicated as being made under a Rule 10b5-1 trading plan. The document’s Rule 10b5-1 checkbox was not marked as affirmative, and no footnote describes a pre-arranged trading arrangement governing these reported entries.